ATE83925T1 - Dosisformen mit definiertem wassergehalt zur gesteuerten freigabe. - Google Patents

Dosisformen mit definiertem wassergehalt zur gesteuerten freigabe.

Info

Publication number
ATE83925T1
ATE83925T1 AT89305209T AT89305209T ATE83925T1 AT E83925 T1 ATE83925 T1 AT E83925T1 AT 89305209 T AT89305209 T AT 89305209T AT 89305209 T AT89305209 T AT 89305209T AT E83925 T1 ATE83925 T1 AT E83925T1
Authority
AT
Austria
Prior art keywords
controlled release
water content
dosage forms
defined water
dosage form
Prior art date
Application number
AT89305209T
Other languages
English (en)
Inventor
Joanne Heafield
Stewart Thomas Leslie
Sandra Therese Antoi Malkowska
Philip John Neale
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of ATE83925T1 publication Critical patent/ATE83925T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT89305209T 1988-06-02 1989-05-23 Dosisformen mit definiertem wassergehalt zur gesteuerten freigabe. ATE83925T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888813064A GB8813064D0 (en) 1988-06-02 1988-06-02 Controlled release dosage forms having defined water content
EP89305209A EP0344960B1 (de) 1988-06-02 1989-05-23 Dosisformen mit definiertem Wassergehalt zur gesteuerten Freigabe

Publications (1)

Publication Number Publication Date
ATE83925T1 true ATE83925T1 (de) 1993-01-15

Family

ID=10637952

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89305209T ATE83925T1 (de) 1988-06-02 1989-05-23 Dosisformen mit definiertem wassergehalt zur gesteuerten freigabe.

Country Status (19)

Country Link
US (1) US5091189A (de)
EP (1) EP0344960B1 (de)
JP (1) JPH0816060B2 (de)
KR (1) KR0136279B1 (de)
AT (1) ATE83925T1 (de)
AU (1) AU610401B2 (de)
CA (1) CA1323834C (de)
DE (1) DE68904119T2 (de)
DK (1) DK175130B1 (de)
ES (1) ES2053989T3 (de)
FI (1) FI93695C (de)
GB (2) GB8813064D0 (de)
GR (1) GR3007088T3 (de)
IE (1) IE61998B1 (de)
IL (1) IL90462A (de)
NO (1) NO176232C (de)
NZ (1) NZ229372A (de)
PT (1) PT90722B (de)
ZA (1) ZA894201B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
RS50070B (sr) 1997-12-22 2009-01-22 Euro-Celtique S.A., Oralni dozni oblik sa kombinacijom opijatnog agonista i antagonista
US6228863B1 (en) * 1997-12-22 2001-05-08 Euro-Celtique S.A. Method of preventing abuse of opioid dosage forms
EP2311441A1 (de) 1998-11-23 2011-04-20 Bonnie M. Davis Dosisformulierungen für Acetylcholinesterase-inhibitoren
JP2003522146A (ja) * 2000-02-08 2003-07-22 ユーロ−セルティーク，エス．エイ． 外圧に抵抗性の経口オピオイドアゴニスト製剤
ATE493130T1 (de) 2001-05-11 2011-01-15 Endo Pharmaceuticals Inc Opioid enthaltende arzneiform gegen missbrauch
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
DK1416842T3 (da) * 2001-07-18 2009-03-16 Euro Celtique Sa Farmaceutiske kombinationer af oxycodon og naloxon
US20030157168A1 (en) * 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
NZ530971A (en) 2001-08-06 2004-08-27 Euro Celtique S Oral dosage forms comprising an opioid agonist with releasable and sequestered opioid antagonists
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
IN192180B (de) * 2001-09-28 2004-03-06 Ranbaxy Lab
PT1485078E (pt) * 2002-03-15 2013-01-14 Cypress Bioscience Inc Milnacipran para o tratamento do síndrome do intestino irritável
EP1492505B1 (de) 2002-04-05 2015-06-03 Euro-Celtique S.A. Pharmazeutische zubereitung enthaltend oxycodon und naloxon
AU2003270778B2 (en) * 2002-09-20 2009-10-08 Alpharma Pharmaceuticals, Llc Sequestering subunit and related compositions and methods
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
MXPA05008033A (es) * 2003-01-28 2006-04-28 Collegium Pharmaceutical Inc Composiciones de milnacipran en forma de multiparticulas para administracion oral.
US20040202717A1 (en) * 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (de) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioide zur Behandlung der chronischen obstruktiven Lungenkrankheit
DE602005011326D1 (de) * 2004-10-19 2009-01-08 Krka Tovarna Zdravil D D Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid
EP1702558A1 (de) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Verfahren und Vorrichtung zur Darmtätigkeitserfassung
EP1942875B1 (de) * 2005-08-24 2015-08-12 Rubicon Research Private Limited Formulierung mit kontrollierter freisetzung
PT2034975E (pt) * 2006-06-19 2012-06-25 Alpharma Pharmaceuticals Llc Composições farmacêuticas
CN105213247A (zh) * 2006-09-29 2016-01-06 宝洁公司 包含凝胶网络的口腔组合物
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
WO2009088673A2 (en) * 2007-12-17 2009-07-16 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
KR20130105935A (ko) * 2008-07-07 2013-09-26 유로-셀티큐 에스.에이. 요폐의 치료를 위한 아편유사제 길항제의 용도
LT2405915T (lt) 2009-03-10 2019-03-12 Euro-Celtique S.A. Greito atpalaidavimo farmacinė kompozicija, apimanti oksikodoną ir naloksoną
AU2014295042B2 (en) 2013-07-23 2017-03-30 Mundipharma Pty Limited A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
CN114053235B (zh) * 2020-08-07 2023-07-18 广州白云山光华制药股份有限公司 茶碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
FR2535202B1 (fr) * 1982-11-03 1985-08-09 Fabre Sa Pierre Comprimes de theophylline a liberation controlee et leur procede de fabrication
US4743247A (en) * 1984-08-13 1988-05-10 Alza Corporation Process for manufacturing dosage form
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
EP0249347B1 (de) * 1986-06-10 1994-06-29 Euroceltique S.A. Zusammensetzung mit kontrollierter Freisetzung von Dihydrocodein
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids

Also Published As

Publication number Publication date
PT90722A (pt) 1989-12-29
ZA894201B (en) 1990-03-28
IL90462A0 (en) 1990-01-18
GR3007088T3 (de) 1993-07-30
FI93695B (fi) 1995-02-15
GB8813064D0 (en) 1988-07-06
NO176232C (no) 1995-03-01
NZ229372A (en) 1991-07-26
IL90462A (en) 1993-01-31
DK266889A (da) 1989-12-03
FI93695C (fi) 1995-05-26
PT90722B (pt) 1994-11-30
EP0344960A2 (de) 1989-12-06
IE61998B1 (en) 1994-12-14
DK266889D0 (da) 1989-06-01
EP0344960B1 (de) 1992-12-30
GB2219207B (en) 1992-01-02
EP0344960A3 (en) 1990-03-07
JPH0816060B2 (ja) 1996-02-21
US5091189A (en) 1992-02-25
JPH0225420A (ja) 1990-01-26
GB2219207A (en) 1989-12-06
DE68904119D1 (de) 1993-02-11
NO176232B (no) 1994-11-21
NO892229D0 (no) 1989-06-01
DE68904119T2 (de) 1993-06-09
GB8911629D0 (en) 1989-07-05
FI892664A (fi) 1989-12-03
KR900000077A (ko) 1990-01-30
FI892664A0 (fi) 1989-06-01
ES2053989T3 (es) 1994-08-01
AU3512789A (en) 1989-12-07
DK175130B1 (da) 2004-06-14
CA1323834C (en) 1993-11-02
NO892229L (no) 1989-12-04
AU610401B2 (en) 1991-05-16
IE891744L (en) 1989-12-02
KR0136279B1 (ko) 1998-04-25

Similar Documents

Publication Publication Date Title
ATE83925T1 (de) Dosisformen mit definiertem wassergehalt zur gesteuerten freigabe.
ATE65386T1 (de) Verwendung von poroesen fuellstoffen in polymerisierbaren dentalmassen, solche massen und deren verwendung zur herstellung von formkoerpern.
FR2646673B1 (fr) Silice sous forme de bille, procede de preparation et son utilisation au renforcement des elastomeres
AU562938B2 (en) 7, 10, 13, 16 docosatetraenoic acid composition
GB8620484D0 (en) Plugged microporous film
GR3004208T3 (de)
FR2640505B1 (fr) Preparation pour l'apport de fer, preparation pour l'apport de vitamines et procede pour stabiliser une preparation effervescente
IT1215332B (it) Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
FI871116A0 (fi) Kontrollerbart frigoerande nifedipinprodukter.
ZA885372B (en) Nutrieut mixture intended for the elderly
FR2518881B1 (fr) Medicaments a base de 26,23-lactones de la 25-hydroxyvitamine d3, utiles notamment pour agir sur la concentration en calcium du serum
EP0206890A3 (en) Product for feeding ruminants and its preparation
IT8882523A0 (it) Metodo per l'avanzamento del piede particolarmente nei pedali per velocipedi.
ATA188385A (de) Verwendung von peroxydiphosphaten zur herstellung von pharmazeutischen tabletten bzw. pharmazeutischen waesserigen loesungen
PT87804A (pt) Nacelle inclinable ou reversible notamment pour voiture d'enfant
ES2052701T3 (es) Agente hipouricemico que contiene ponalrestat.
FR2640506B1 (fr) Preparation pour l'apport de fer, preparation pour l'apport de vitamines et procede pour stabiliser une preparation effervescente
ATE66611T1 (de) Verwendung biologisch aktiver copolymere zur herstellung eines arzneimittels zur stimulierung des wachstums von tieren.
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time